Accrued liabilities as of September 30, 2024 and December 31, 2023 consisted of the following:
September 30,
December 31,
2024
2023
Accrued personnel related costs
$
876
1,989
Accrued research and development expenses
6,466
6,527
Other accrued expenses
170
313
Total
7,512
8,829
No definition available.
Tabular disclosure of the components of accrued liabilities.